{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:32:39Z","timestamp":1779258759800,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T00:00:00Z","timestamp":1549670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40266-019-00642-3","type":"journal-article","created":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T03:21:26Z","timestamp":1549682486000},"page":"387-393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty: A Longitudinal Cohort Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Nicola","family":"Veronese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Soysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Demurtas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Celotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,9]]},"reference":[{"issue":"14","key":"642_CR1","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","volume":"97","author":"NJ Brown","year":"1998","unstructured":"Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation. 1998;97(14):1411\u201320.","journal-title":"Circulation"},{"issue":"25","key":"642_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"L K\u00f8ber","year":"1995","unstructured":"K\u00f8ber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al. A clinical trial of the angiotensin-converting\u2013enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333(25):1670\u20136.","journal-title":"N Engl J Med"},{"issue":"12","key":"642_CR3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMoa011489","volume":"345","author":"H-H Parving","year":"2001","unstructured":"Parving H-H, Lehnert H, Br\u00f6chner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345(12):870\u20138.","journal-title":"N Engl J Med"},{"issue":"8","key":"642_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1503\/cmaj.071062","volume":"177","author":"A Cranney","year":"2007","unstructured":"Cranney A. Is there a new role for angiotensin-converting-enzyme inhibitors in elderly patients? CMAJ Can Med Assoc J. 2007;177(8):891\u20132.","journal-title":"CMAJ Can Med Assoc J"},{"issue":"243","key":"642_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jad.2018.09.036","volume":"15","author":"G Ashdown-Franks","year":"2019","unstructured":"Ashdown-Franks G, Stubbs B, Koyanagi A, Schuch F, Firth J, Veronese N, et al. Handgrip strength and depression among 34,129 adults aged 50\u00a0years and older in six low- and middle-income countries. J Affect Disord. 2019;15(243):448\u201354.","journal-title":"J Affect Disord"},{"issue":"8","key":"642_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1503\/cmaj.061339","volume":"177","author":"D Sumukadas","year":"2007","unstructured":"Sumukadas D, Witham MD, Struthers AD, McMurdo ME. Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. Can Med Assoc J. 2007;177(8):867\u201374.","journal-title":"Can Med Assoc J"},{"issue":"4","key":"642_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/heart.88.4.373","volume":"88","author":"S Hutcheon","year":"2002","unstructured":"Hutcheon S, Gillespie N, Crombie I, Struthers A, McMurdo M. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart (British Cardiac Society). 2002;88(4):373\u20137.","journal-title":"Heart (British Cardiac Society)"},{"issue":"9868","key":"642_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet (London, England). 2013;381(9868):752\u201362.","journal-title":"Lancet (London, England)"},{"issue":"8","key":"642_CR9","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","volume":"60","author":"RM Collard","year":"2012","unstructured":"Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60(8):1487\u201392.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"642_CR10","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jamda.2015.06.025","volume":"16","author":"G Kojima","year":"2015","unstructured":"Kojima G. Prevalence of frailty in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2015;16(11):940\u20135.","journal-title":"J Am Med Dir Assoc"},{"issue":"35","key":"642_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.arr.2017.01.003","volume":"28","author":"N Veronese","year":"2017","unstructured":"Veronese N, Cereda E, Stubbs B, Solmi M, Luchini C, Manzato E, et al. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis. Ageing Res Rev. 2017;28(35):63\u201373.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"642_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00223-013-9758-y","volume":"93","author":"R Rizzoli","year":"2013","unstructured":"Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013;93(2):101\u201320.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"642_CR13","doi-asserted-by":"publisher","first-page":"M590","DOI":"10.1093\/gerona\/59.6.M590","volume":"59","author":"J-M Robine","year":"2004","unstructured":"Robine J-M, Michel J-P. Looking forward to a general theory on population aging. J Gerontol Ser A Biol Sci Med Sci. 2004;59(6):M590\u20137.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"2","key":"642_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1532-5415.2008.02121.x","volume":"57","author":"SL Gray","year":"2009","unstructured":"Gray SL, LaCroix AZ, Aragaki AK, McDermott M, Cochrane BB, Kooperberg CL, et al. Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women\u2019s Health Initiative Observational Study. J Am Geriatr Soc. 2009;57(2):297\u2013303.","journal-title":"J Am Geriatr Soc"},{"issue":"9310","key":"642_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","volume":"359","author":"G Onder","year":"2002","unstructured":"Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (London, England). 2002;359(9310):926\u201330.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"642_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.mehy.2006.01.047","volume":"67","author":"GA Eby","year":"2006","unstructured":"Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67(2):362\u201370.","journal-title":"Med Hypotheses"},{"key":"642_CR17","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jamda.2017.02.009","volume":"18","author":"N Veronese","year":"2017","unstructured":"Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A, et al. Polypharmacy is associated with higher frailty risk in older people: an 8-year longitudinal cohort study. J Am Med Dir Assoc. 2017;18:624\u20138.","journal-title":"J Am Med Dir Assoc"},{"issue":"108","key":"642_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.exger.2018.04.023","volume":"15","author":"F Bolzetta","year":"2018","unstructured":"Bolzetta F, Wetle T, Besdine R, Noale M, Cester A, Crepaldi G, et al. The relationship between different settings of medical service and incident frailty. Exp Gerontol. 2018;15(108):209\u201314.","journal-title":"Exp Gerontol"},{"issue":"11","key":"642_CR19","doi-asserted-by":"publisher","first-page":"E1253","DOI":"10.3390\/nu9111253","volume":"9","author":"N Veronese","year":"2017","unstructured":"Veronese N, Stubbs B, Maggi S, Notarnicola M, Barbagallo M, Firth J, et al. Dietary magnesium and incident frailty in older people at risk for knee osteoarthritis: an eight-year longitudinal study. Nutrients. 2017;9(11):E1253.","journal-title":"Nutrients"},{"issue":"3","key":"642_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/gerona\/glu102","volume":"70","author":"D Misra","year":"2015","unstructured":"Misra D, Felson DT, Silliman RA, Nevitt M, Lewis CE, Torner J, et al. Knee osteoarthritis and frailty: findings from the Multicenter Osteoarthritis Study and Osteoarthritis Initiative. J Gerontol Ser A Biol Sci Med Sci. 2015;70(3):339\u201344.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"11","key":"642_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/obr.12309","volume":"16","author":"N Veronese","year":"2015","unstructured":"Veronese N, Cereda E, Solmi M, Fowler SA, Manzato E, Maggi S, et al. Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects. Obes Rev. 2015;16(11):1001\u201315.","journal-title":"Obes Rev"},{"issue":"3","key":"642_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware","year":"1996","unstructured":"Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"issue":"3","key":"642_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/BOR.0000000000000161","volume":"27","author":"KD Allen","year":"2015","unstructured":"Allen KD, Golightly YM. Epidemiology of osteoarthritis: state of the evidence. Curr Opin Rheumatol. 2015;27(3):276\u201383.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"642_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1037\/0882-7974.12.2.277","volume":"12","author":"PM Lewinsohn","year":"1997","unstructured":"Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging. 1997;12(2):277\u201387.","journal-title":"Psychol Aging"},{"issue":"7","key":"642_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0895-4356(99)00049-9","volume":"52","author":"RA Washburn","year":"1999","unstructured":"Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999;52(7):643\u201351.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"642_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00005650-199601000-00006","volume":"34","author":"JN Katz","year":"1996","unstructured":"Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996;34(1):73\u201384.","journal-title":"Med Care"},{"key":"642_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/acr.23735","volume":"1","author":"N Veronese","year":"2018","unstructured":"Veronese N, Koyanagi A, Stubbs B, Cooper C, Guglielmi G, Rizzoli R, et al. Statin use and knee osteoarthritis outcomes: a longitudinal cohort study. Arthritis Care Res. 2018;1:1. \n                              https:\/\/doi.org\/10.1002\/acr.23735\n                              \n                           .","journal-title":"Arthritis Care Res"},{"key":"642_CR28","unstructured":"Miles J. Tolerance and variance inflation factor. Wiley StatsRef: Statistics Reference Online; 2009."},{"issue":"15","key":"642_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","volume":"314","author":"JS Haukoos","year":"2015","unstructured":"Haukoos JS, Lewis RJ. The Propensity Score. JAMA. 2015;314(15):1637\u20138.","journal-title":"JAMA"},{"issue":"7","key":"642_CR30","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/bcp.13590","volume":"84","author":"M Guti\u00e9rrez-Valencia","year":"2018","unstructured":"Guti\u00e9rrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero \u00c1, Inzitari M, Mart\u00ednez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84(7):1432\u201344.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"642_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jamda.2017.02.009","volume":"18","author":"N Veronese","year":"2017","unstructured":"Veronese N, Stubbs B, Noale M, Solmi M, Pilotto A, Vaona A, et al. Polypharmacy is associated with higher frailty risk in older people: an 8-year longitudinal cohort study. J Am Med Dir Assoc. 2017;18(7):624\u20138.","journal-title":"J Am Med Dir Assoc"},{"issue":"11","key":"642_CR32","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1006\/jmcc.1998.0806","volume":"30","author":"M Kitakaze","year":"1998","unstructured":"Kitakaze M, Node K, Minamino T, Asanuma H, Ueda Y, Kosaka H, et al. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium. J Mol Cell Cardiol. 1998;30(11):2461\u20136.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"642_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1152\/physrev.2001.81.1.209","volume":"81","author":"JS Stamler","year":"2001","unstructured":"Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev. 2001;81(1):209\u201337.","journal-title":"Physiol Rev"},{"issue":"1","key":"642_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1469-7793.1999.0189o.x","volume":"519","author":"TJ Koh","year":"1999","unstructured":"Koh TJ, Tidball JG. Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle. J Physiol. 1999;519(1):189\u201396.","journal-title":"J Physiol"},{"issue":"12","key":"642_CR35","doi-asserted-by":"publisher","first-page":"e111952","DOI":"10.1371\/journal.pone.0111952","volume":"9","author":"KE Kortekaas","year":"2014","unstructured":"Kortekaas KE, Meijer CA, Hinnen JW, Dalman RL, Xu B, Hamming JF, et al. ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm. PLoS One. 2014;9(12):e111952.","journal-title":"PLoS One"},{"key":"642_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2016.08.006","volume":"31","author":"P Soysal","year":"2016","unstructured":"Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1\u20138.","journal-title":"Ageing Res Rev"},{"key":"642_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","volume":"96","author":"G Bano","year":"2017","unstructured":"Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B, et al. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas. 2017;96:10\u20135.","journal-title":"Maturitas"},{"issue":"4","key":"642_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4081\/ejtm.2015.5227","volume":"25","author":"L Barberi","year":"2015","unstructured":"Barberi L, Scicchitano BM, Musar\u00f2 A. Molecular and cellular mechanisms of muscle aging and sarcopenia and effects of electrical stimulation in seniors. Eur J Transl Myol. 2015;25(4):231\u20136.","journal-title":"Eur J Transl Myol"},{"issue":"1 Pt 1","key":"642_CR39","doi-asserted-by":"publisher","first-page":"C15","DOI":"10.1152\/ajpcell.1993.265.1.C15","volume":"265","author":"L Ferder","year":"1993","unstructured":"Ferder L, Inserra F, Romano L, Ercole L, Pszenny V. Effects of angiotensin-converting enzyme inhibition on mitochondrial number in the aging mouse. Am J Physiol. 1993;265(1 Pt 1):C15\u20138.","journal-title":"Am J Physiol"},{"key":"642_CR40","doi-asserted-by":"publisher","first-page":"k4209","DOI":"10.1136\/bmj.k4209","volume":"363","author":"BM Hicks","year":"2018","unstructured":"Hicks BM, Filion KB, Yin H, Sakr L, Udell JA, Azoulay L. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study. BMJ. 2018;363:k4209.","journal-title":"BMJ"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-019-00642-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00642-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00642-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,9]],"date-time":"2020-02-09T00:19:02Z","timestamp":1581207542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-019-00642-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,9]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1007\/s40266-019-00642-3","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,9]]},"assertion":[{"value":"9 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) from the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private-sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Veronese, Stubbs, Smith, Maggi, Jackson, Soysal, Demurtas, Celotto and Koyanagi declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}